A venture capital firm focused on early-stage companies addressing unmet needs in healthcare.

Rhythm VC

We invest and partner with early-stage companies taking transformational approaches to address significant unmet needs in healthcare.

Will you be in New Orleans this year for the American Rhinologic Society's Summer Sinus Meeting? 

If so, we'd love for you to join our evening reception (see below)!

We're incredibly excited by the recognition by MedTech Innovator and thrilled to be part of such an incredible cohort of innovative companies!

https://lnkd.in/eq8zbHmR

Meet VitalOne, a compact blood analysis device designed with the latest advances in robotics, biochemistry, computer vision, and microfluidics to deliver lab-grade results in the doctor’s office in minutes.

Cofounder and CEO of Vital Bio Vasu Nadella offered a live introduction to the #FortuneHealth audience. bit.ly/3Wsi6Ph

Australian disability tech accelerator Remarkable Tech has backed a US med tech startup reducing urinary tract infection (UTI) risks in a US$6 million (A$9.1m) Seed raise.

The best team wins.

We are thrilled to welcome Douglas Bryant to our board. Doug joins us after a storied career at companies like Abbott, Luminex, and leading Quidel for 15 years. His strategic insights, extensive network, and industry wisdom have already proven invaluable to our team.

Doug will join our existing independent Board of Director members Matt Posard, who held executive roles with several high growth companies including Illumina and Biosite, and Dr. Marcia Eisenberg, Chief Science Officer and a veteran of LabCorp for more than 25 years.

https://lnkd.in/gPkpe2A9

RHYT

COM:RHYTHMVC

Rhythm VC